ask="11.30"
ask_size="300"
average_daily_volume="207762"
bid="9.05"
bid_size="100"
book_value="2.66"
change="+0.00"
change_from_200_day_moving_average="2.00"
change_from_50_day_moving_average="1.43"
change_from_52_week_high="-1.63"
change_From_52_week_low="3.50"
change_in_percent="+0.00%"
close="10.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.04"
eps_estimate_next_quarter="-0.58"
eps_estimate_next_year="-1.71"
ex_dividend_date="N/A"
float_shares="15519000"
high="10.69"
high_52_weeks="12.13"
last_trade_date="1/4/2017"
last_trade_price="10.50"
last_trade_size="40863"
last_trade_time="4:00pm"
low="10.43"
low_52_weeks="7.00"
market_capitalization="192.15M"
moving_average_200_day="8.50"
moving_average_50_day="9.07"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.61"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+23.54%"
percent_change_from_50_day_moving_average="+15.78%"
percent_change_from_52_week_high="-13.44%"
percent_change_from_52_week_low="+50.00%"
previous_close="10.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.95"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="13.24"
stock_exchange="NGM"
symbol="AKBA"
volume="315728"
weeks_range_52="7.00 - 12.13"
